Cardiff Lexington Corporation financials

CDIX CIK 0000811222

Source: EDGAR filings · Built 2026-06-19T02:08:01Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -1.15M -853.55K -903.42K
EBITDA 1.11M -180.04K 5.22M 3.93M 1.68M -1.78M
Working Capital -3.24M 1.33M 316.63K -3.14M -4.58M -13.11M
Net Debt 18.46M 8.43M 5.36M 3.57M 1.80M 3.25M
Gross Margin 62.47% 53.55% 69.96% 62.03% 61.85% 51.69%
Operating Margin 9.54% -2.34% 43.83% 36.54% 16.82% -52.25%
Net Margin -47.74% -39.94% 25.55% -50.78% 6.74% -82.16%
Return on Equity (ROE) 223.01% -123.01% 414.04% 311.18% 136.86% 31.97%
Return on Assets (ROA) -18.93% -13.81% 14.60% -40.69% 4.36% -57.54%
Current Ratio 0.87× 1.08× 1.02× 0.69× 0.59× 0.02×
Debt-to-Equity -7.61× 3.58× 8.52× -2.17× 4.88× -0.40×
Effective Tax Rate 0.00%
Cash Conversion Ratio 0.52× 0.84× -0.57× 0.21× -1.28× 0.32×
Accruals Ratio -0.09× -0.02× 0.23× -0.32× 0.10× -0.39×
SBC % of Revenue 6.54% 6.59% 0.00%
CapEx Coverage -249.53×
Free Cash Flow Per Share $-0.20 $0.00 $-0.00

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 11.54M 8.27M 11.85M 10.69M 9.88M 3.45M
Cost of Revenue 4.33M 3.84M 3.56M 4.06M 3.77M 1.67M
Gross Profit 7.21M 4.43M 8.29M 6.63M 6.11M 1.78M
Selling, General and Administrative Expense 5.33M 4.06M 3.08M 2.70M 4.43M 3.59M
Operating Expenses 6.11M 4.62M 3.10M 2.73M 4.45M 3.59M
Operating Income (Loss) 1.10M -193.50K 5.20M 3.91M 1.66M -1.80M
Income Tax Expense (Benefit) 0
Net Income (Loss) Attributable to Parent -5.51M -3.30M 3.03M -5.43M 666.29K -2.84M
Earnings Per Share, Basic $-0.01
Weighted Average Number of Shares Outstanding, Basic 6.93M 3.82M 14,444 5,822 128.02M 908,485
Earnings Per Share, Diluted $-0.01
Weighted Average Number of Shares Outstanding, Diluted 8.50B 3.82B 15.00M 5.82M 128.02B 908.49M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 279.31K
Assets, Current 22.59M 17.21M 14.18M 6.83M 6.59M 295.69K
Assets 29.09M 23.93M 20.75M 13.34M 15.30M 4.93M
Long-term Debt 18.56M 9.21M 2.28M 155.60K 600.93K
Liabilities, Current 25.83M 15.89M 13.86M 9.96M 11.17M 13.40M
Liabilities 26.01M 16.32M 14.12M 10.19M 11.44M 13.80M
Stockholders' Equity Attributable to Parent -2.47M 2.69M 731.42K -1.74M 486.84K -8.87M
Common Stock, Shares, Outstanding 13.70M 5.10M 25,121 10,997 166.13M 5.27M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -1.72M -1.15M
Payments to Acquire Property, Plant, and Equipment 0 3.41K 0
Net Cash Provided by (Used in) Investing Activities 0 -2.32M
Payments of Dividends 50.00K 100.00K
Net Cash Provided by (Used in) Financing Activities 1.98M 2.98M 2.37M 788.79K 3.68M 1.15M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CDIX CIK 0000811222), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

GNTA

Genenta Science S.p.A.

PSIX

POWER SOLUTIONS INTERNATIONAL, INC.

AMRX

Amneal Pharmaceuticals, Inc.